Validation of prognostic scoring and assessment of clinical benefit for patients with bone sarcomas enrolled in phase I clinical trials

BACKGROUND: We sought to validate the Royal Marsden Hospital (RMH) and MD Anderson Cancer Center (MDACC) prognostic scoring systems for the selection of bone sarcoma patients for phase I clinical trials and to identify additional risk factors related to survival. PATIENTS AND METHODS: We retrospecti...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Oncotarget
Päätekijät: Livingston, J. Andrew, Hess, Kenneth R., Naing, Aung, Hong, David S., Patel, Shreyaskumar, Benjamin, Robert S., Ludwig, Joseph A., Conley, Anthony, Herzog, Cynthia E., Anderson, Pete, Meric-Bernstam, Funda, Kurzrock, Razelle, Subbiah, Vivek
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Impact Journals LLC 2016
Aiheet:
Clinical Research Paper
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC5325454/
https://ncbi.nlm.nih.gov/pubmed/27486883
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.10910
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia